TBCA
TBCA is a highly selective CK2 (casein kinase II) inhibitor with an IC50 of 110 nM and a Ki of 77 nM. TBCA shows selectivity for CK2 over CK1, DYRK1A and a panel of 27 other kinases[1][2].
Product Specifications
CAS Number
934358-00-6
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Casein Kinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tbca.html
Concentration
10mM
Purity
99.45
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC(/C=C/C1=C(C(Br)=C(Br)C(Br)=C1)Br)=O
Molecular Formula
C9H4Br4O2
Molecular Weight
463.74
Precautions
H315, H319, H335
References & Citations
[1]Pagano MA, et al. Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors. Chembiochem. 2007;8 (1) :129-139.|[2]Ryu SY, Kim S. Evaluation of CK2 inhibitor (E) -3- (2,3,4,5-tetrabromophenyl) acrylic acid (TBCA) in regulation of platelet function. Eur J Pharmacol. 2013;720 (1-3) :391-400.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS146439-20ug 20 µg
CCDC64B (BICDL2) (NM_001103175) Human Over-expression Lysate
Sign In for Pricing
View Details 
H00081611-P01-25ug 25 µg
Recombinant Human LANPL Protein - (Dry Ice)
Sign In for Pricing
View Details